Literature DB >> 9406781

Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR.

W Luo1, F Aosai, M Ueda, K Yamashita, K Shimizu, S Sekiya, A Yano.   

Abstract

The kinetics of changes in Toxoplasma gondii abundance were evaluated with a quantitative competitive (QC)-polymerase chain reaction (PCR) assay at various sites in both C57BL/6 and BALB/c mice. Higher mortality was apparent in C57BL/6 mice than in BALB/c mice when infected with a high dose of cysts. There were significant differences in cyst number when infected with a low dose of cysts, although there was no significant difference in mortality between the 2 mouse strains. One day after infection with a low dose of an avirulent Fukaya strain, T. gondii was detected in peripheral blood, mesenteric lymph nodes, spleen, lungs, and brain. Two weeks after infection, the number of T. gondii in the brain greatly increased in C57BL/6 mice but not in BALB/c mice. Thus, it would appear that the first to second week after infection is a critical period in determining T. gondii abundance. QC PCR allows the detection of low numbers of T. gondii at an early stage of infection in the murine model. This is useful for the early diagnosis of toxoplasmosis and to understand reactivation of toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406781

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  13 in total

1.  Quantitation of Toxoplasma gondii DNA in a competitive nested polymerase chain reaction.

Authors:  P Y Lee; J Mangan; R E Holliman; P D Butcher
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

2.  Experimental ocular toxoplasmosis in genetically susceptible and resistant mice.

Authors:  Fangli Lu; Shiguang Huang; Mark S Hu; Lloyd H Kasper
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  A role of carboxy-terminal region of Toxoplasma gondii-heat shock protein 70 in enhancement of T. gondii infection in mice.

Authors:  H S Mun; K Norose; F Aosai; M Chen; A Yano
Journal:  Korean J Parasitol       Date:  2000-06       Impact factor: 1.341

4.  Development of a real-time PCR assay for detection of Toxoplasma gondii in pig and mouse tissues.

Authors:  L H Jauregui; J Higgins; D Zarlenga; J P Dubey; J K Lunney
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Toxoplasma gondii infection inhibits Th17-mediated spontaneous development of arthritis in interleukin-1 receptor antagonist-deficient mice.

Authors:  Takuya Washino; Masataka Moroda; Yoichiro Iwakura; Fumie Aosai
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

6.  Transcriptome analysis of mouse brain infected with Toxoplasma gondii.

Authors:  Sachi Tanaka; Maki Nishimura; Fumiaki Ihara; Junya Yamagishi; Yutaka Suzuki; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2013-07-15       Impact factor: 3.441

7.  Toxoplasma gondii Hsp70 as a danger signal in toxoplasma gondii-infected mice.

Authors:  H S Mun; F Aosai; K Norose; M Chen; H Hata; Y I Tagawa; Y Iwakura; D S Byun; A Yano
Journal:  Cell Stress Chaperones       Date:  2000-10       Impact factor: 3.667

8.  Anti-HSP70 autoantibody formation by B-1 cells in Toxoplasma gondii-infected mice.

Authors:  M Chen; F Aosai; H S Mun; K Norose; H Hata; A Yano
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

9.  Interleukin-17A-Deficient Mice Are Highly Susceptible to Toxoplasma gondii Infection Due to Excessively Induced T. gondii HSP70 and Interferon Gamma Production.

Authors:  Masataka Moroda; Masaya Takamoto; Yoichiro Iwakura; Jun Nakayama; Fumie Aosai
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

10.  Temporal distribution and parasite load kinetics in blood and tissues during Neospora caninum infection in mice.

Authors:  Esther Collantes-Fernández; Inmaculada López-Pérez; Gema Alvarez-García; Luis M Ortega-Mora
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.